Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
26.55
-1.26 (-4.55%)
Jul 28, 2026, 3:24 PM EDT - Market open
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.74 billion as of July 28, 2026. Its market cap has increased by 172.18% in one year.
Market Cap
1.74B
Enterprise Value
1.23B
1-Year Change
172.18%
Ranking
Category
Stock Price
$26.55
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.74B, an increase of 87.20%. That is a compound annual growth rate of 39.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 1.74B | 89.17% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 1.87B |
| Lakefront Biotherapeutics NV | 1.85B |
| Ocular Therapeutix | 1.83B |
| Tyra Biosciences | 1.83B |
| Monte Rosa Therapeutics | 1.81B |
| Damora Therapeutics | 1.79B |
| Stoke Therapeutics | 1.79B |
| Maravai LifeSciences Holdings | 1.78B |